Company: RPID
Filing Date: 2025-11-07
Form Type: 10-Q
Source: 0001380106-25-000200
Chunk: 349

Company: RAPID MICRO BIOSYSTEMS, INC.
Filing Date: 2025-11-07
Form: 10-Q
Item: Part I, Item 8
Chunk 349
---
 September 30,20252024Risk-free interest rate 4.3 %4.3 %Expected term (in years)6.05.9Expected volatility51.7 %50.0 %Expected dividend yield0 %0 %Stock optionsThe following table summarizes the Company’s stock option activity since December 31, 2024:Number of sharesWeighted average exercise priceWeighted average remaining contractual termAggregate intrinsic value(in years)(in thousands)Outstanding as of December 31, 20246,296,505$2.39 6.18$135 Granted 1,454,2503.43 Exercised(437,302)1.10 $659 Expired(273,827)8.46 Forfeited(204,874)2.45 Outstanding as of September 30, 20256,834,752$2.45 6.03$10,979 Options vested and expected to vest as of September 30, 20256,834,752$2.45 6.03$10,979 Options exercisable as of September 30, 20254,718,260$2.38 5.28$8,916 The aggregate intrinsic value of options is calculated as the difference between the exercise price of the stock options and the fair value of the Company’s Class A common stock for those options that had exercise prices lower than such fair value.The intrinsic value of stock options exercised during each of the three months ended September 30, 2025 and 2024 was $0.1 million, and during the nine months ended September 30, 2025 and 2024 was $0.7 million and less than $0.1 million, respectively. 

26

The weighted average grant-date fair value per share of stock options granted during the nine months ended September 30, 2025 and 2024 was $1.80 and $0.48, respectively. No options were granted in the three months ended September 30,  2025 and 2024. Restricted stock unitsRestricted stock unit grants  typically have service-based vesting terms from one to three years. Vesting occurs annually on the anniversary of the grant date. During the nine months ended September 30, 2025, the Company granted restricted stock units with service-based vesting conditions only. The Company expenses the fair value of the restricted stock units over the expected vesting